[HTML][HTML] Refining patient selection for breast cancer immunotherapy: beyond PD-L1
M Kossai, N Radosevic-Robin, F Penault-Llorca - ESMO open, 2021 - Elsevier
Therapies that modulate immune response to cancer, such as immune checkpoint inhibitors,
began an intense development a few years ago; however, in breast cancer (BC), the results …
began an intense development a few years ago; however, in breast cancer (BC), the results …